CANTHARIDIN

CANTHARIDIN was reported 183 times

These side effects are most commonly reported by patients taking CANTHARIDIN:

# Side effect Count
0 APPLICATION SITE VESICLES 78
1 APPLICATION SITE PAIN 53
2 BLISTER 30
3 PAIN 16
4 APPLICATION SITE BURN 12
5 BLISTER RUPTURE 8
6 HYPERSENSITIVITY 8
7 APPLICATION SITE ERYTHEMA 7
8 DRUG INEFFECTIVE 7
9 ACCIDENTAL EXPOSURE TO PRODUCT 6
10 CHEMICAL BURN 6
11 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6
12 BLOOD BLISTER 5
13 PRODUCT USE ISSUE 5
14 PYREXIA 5
15 SKIN EXFOLIATION 5
16 ACUTE KIDNEY INJURY 4
17 APPLICATION SITE INFECTION 4
18 APPLICATION SITE PRURITUS 4
19 APPLICATION SITE REACTION 4
20 OFF LABEL USE 4
21 PRODUCT ADMINISTERED BY WRONG PERSON 4
22 APPLICATION SITE DISCOLOURATION 3
23 APPLICATION SITE DISCOMFORT 3
24 APPLICATION SITE HAEMORRHAGE 3
25 CRYING 3
26 FATIGUE 3
27 GAIT DISTURBANCE 3
28 HYPERURICAEMIA 3
29 IMPETIGO 3
30 LETHARGY 3
31 NAUSEA 3
32 PRODUCT DELIVERY MECHANISM ISSUE 3
33 PRODUCT PHYSICAL CONSISTENCY ISSUE 3
34 THERMAL BURN 3
35 URTICARIA 3
36 WOUND 3
37 ABDOMINAL PAIN 2
38 ADVERSE DRUG REACTION 2
39 APPLICATION SITE EROSION 2
40 APPLICATION SITE IRRITATION 2
41 APPLICATION SITE SCAB 2
42 APPLICATION SITE SCAR 2
43 BURNING SENSATION 2
44 DIARRHOEA 2
45 DISCOMFORT 2
46 DRUG INTERACTION 2
47 DRUG RESISTANCE 2
48 EXTRA DOSE ADMINISTERED 2
49 HAEMORRHAGE 2
50 HYPERCHOLESTEROLAEMIA 2
51 INFECTION 2
52 INJURY ASSOCIATED WITH DEVICE 2
53 LIP BLISTER 2
54 LIQUID PRODUCT PHYSICAL ISSUE 2
55 LOSS OF CONSCIOUSNESS 2
56 MALAISE 2
57 MUSCLE RIGIDITY 2
58 POST PROCEDURAL COMPLICATION 2
59 PRODUCT COMMUNICATION ISSUE 2
60 PRODUCT PACKAGE ASSOCIATED INJURY 2
61 PRODUCT PRESCRIBING ERROR 2
62 RASH 2
63 RENAL IMPAIRMENT 2
64 SCREAMING 2
65 SKIN DISORDER 2
66 SKIN LACERATION 2
67 SKIN REACTION 2
68 SKIN TIGHTNESS 2
69 TREATMENT FAILURE 2
70 VOMITING 2
71 ACTIVITIES OF DAILY LIVING DECREASED 1
72 ADVERSE EVENT 1
73 ANAEMIA 1
74 ANAL INCONTINENCE 1
75 ANOGENITAL WARTS 1
76 APPLICATION SITE DISCHARGE 1
77 APPLICATION SITE EXFOLIATION 1
78 APPLICATION SITE INFLAMMATION 1
79 APPLICATION SITE PAPULES 1
80 APPLICATION SITE PLAQUE 1
81 APPLICATION SITE RASH 1
82 APPLICATION SITE URTICARIA 1
83 APPLICATION SITE WARMTH 1
84 APPLICATION SITE WOUND 1
85 BACTERIAL INFECTION 1
86 BLISTER INFECTED 1
87 BURNS SECOND DEGREE 1
88 CHEMICAL BURNS OF EYE 1
89 CHEST DISCOMFORT 1
90 CIRCULATORY COLLAPSE 1
91 CONDITION AGGRAVATED 1
92 CONFUSIONAL STATE 1
93 CORNEAL ABRASION 1
94 COUGH 1
95 COVID-19 1
96 CRYOTHERAPY 1
97 DEVICE BREAKAGE 1
98 DEVICE DELIVERY SYSTEM ISSUE 1
99 DISEASE PROGRESSION 1
100 DISEASE RECURRENCE 1
101 DISORIENTATION 1
102 DIZZINESS 1
103 DRUG HYPERSENSITIVITY 1
104 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
105 DRUG INTOLERANCE 1
106 DRUG LEVEL FLUCTUATING 1
107 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1
108 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
109 DRY MOUTH 1
110 DYSPNOEA 1
111 DYSPNOEA EXERTIONAL 1
112 ECZEMA 1
113 EFFUSION 1
114 EPSTEIN-BARR VIRAEMIA 1
115 ERYSIPELAS 1
116 ERYTHEMA 1
117 FLUID INTAKE REDUCED 1
118 FURUNCLE 1
119 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1
120 INABILITY TO AFFORD MEDICATION 1
121 INCREASED DOSE ADMINISTERED 1
122 KIDNEY TRANSPLANT REJECTION 1
123 LYMPHADENOPATHY 1
124 MUCOSAL INFECTION 1
125 NASOPHARYNGITIS 1
126 NO THERAPEUTIC RESPONSE 1
127 NON-CARDIAC CHEST PAIN 1
128 ORAL MUCOSAL BLISTERING 1
129 OROPHARYNGEAL PAIN 1
130 OVERDOSE 1
131 PAIN IN JAW 1
132 PAIN OF SKIN 1
133 PARAESTHESIA 1
134 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1
135 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
136 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 1
137 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
138 PRODUCT COLOUR ISSUE 1
139 PRODUCT DISTRIBUTION ISSUE 1
140 PRODUCT DOSE OMISSION ISSUE 1
141 PRODUCT KNOWLEDGE DEFICIT 1
142 PRODUCT LABEL ISSUE 1
143 PRODUCT PACKAGING QUANTITY ISSUE 1
144 PRODUCT QUALITY ISSUE 1
145 PRODUCT USE IN UNAPPROVED INDICATION 1
146 RASH ERYTHEMATOUS 1
147 RENAL DISORDER 1
148 RENAL TUBULAR DISORDER 1
149 SCAB 1
150 SCAR 1
151 SCRATCH 1
152 SECRETION DISCHARGE 1
153 SEIZURE 1
154 SKIN ABRASION 1
155 SKIN BACTERIAL INFECTION 1
156 SKIN EROSION 1
157 SKIN FISSURES 1
158 SKIN INFECTION 1
159 SKIN INJURY 1
160 SKIN PAPILLOMA 1
161 SKIN PLAQUE 1
162 SKIN TEMPERATURE INCREASED 1
163 STAPHYLOCOCCAL SKIN INFECTION 1
164 SUPERINFECTION 1
165 SWELLING OF EYELID 1
166 SYNCOPE 1
167 THERAPEUTIC PRODUCT EFFECT DELAYED 1
168 THERAPY NON-RESPONDER 1
169 THINKING ABNORMAL 1
170 TREATMENT DELAYED 1
171 ULNA FRACTURE 1
172 URINARY BLADDER RUPTURE 1
173 VULVOVAGINAL PAIN 1